证券代码：600141 证券简称：兴发集团 公告编号：临2023-047 债券代码：110089 债券简称：兴发转债 湖北兴发化工集团股份有限公司 关于参加 2023 年湖北辖区上市公司投资者网上集体接待日 活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ●活动内容："2023 年湖北辖区上市公司投资者网上集体接待日"活动 ●活动时间：2023 年 5 月 25 日（星期四）14:30-16:35 ●活动地点：全景路演（http://rs.p5w.net）网络平台 ●预征集投资者提问的相关安排：投资者可于 2023 年 5 月 24 日（周三） 17:00 前访问 https://ir.p5w.net/zj/，进入问题征集专题页面，向本公司提 出您关注的问题。 一、活动主题 为进一步加强与广大投资者的互动交流，根据湖北省上市公司协会《关于 举办2023年湖北辖区上市公司投资者网上集体接待日活动的通知》统一部署， 湖北兴发化工集团股份有限公司（以下简称"公司"）将于2023年5月25日（ 星期四 ...

| | | 湖北兴发化工集团股份有限公司 关于召开 2022 年度暨 2023 年第一季度网上业绩说明会的 公 告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ●会议内容："兴发集团 2022 年度暨 2023 年第一季度业绩说明会" ●会议时间：2023 年 5 月 22 日 10:00-11:30 ●会议形式：上证路演中心视频直播和网络互动 ●网络直播地址：上证路演中心（http://roadshow.sseinfo.com） ●投资者可于2023 年5月21日16:00 前将相关问题通过电子邮件形式发 送至公司邮箱：dmb@xingfagroup.com。公司将会于 2022 年度暨 2023 年第一 季度网上业绩说明会（以下简称"业绩说明会"）上在信息披露允许的范围内 对投资者普遍关注的问题进行回答。 一、业绩说明会主题 公司 2022 年度报告、2023 年一季度报告已对外公布（详见 2023 年 3 月 21 日、2023 年 4 月 29 日《上海证券报》《中国证券报》《证券时报》《证券 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥6,571,156,048.61, a decrease of 25.02% compared to ¥8,763,784,018.25 in the same period last year[4] - Net profit attributable to shareholders of the listed company was ¥449,309,504.76, down 74.21% from ¥1,742,421,263.31 in the previous year[4] - Basic and diluted earnings per share were both ¥0.40, a decrease of 74.52% from ¥1.57 in the previous year[5] - The weighted average return on net assets was 2.19%, down 9.57 percentage points from 11.76% in the previous year[5] - The net profit after deducting non-recurring gains and losses was ¥411,756,747.02, a decrease of 75.67% from ¥1,692,514,628.17 in the previous year[5] - The company reported a significant decline in sales volume and market prices of some main products during the reporting period, impacting overall profitability[9] - Net profit for Q1 2023 was CNY 467,490,336.92, a significant decline from CNY 2,138,990,843.50 in Q1 2022, representing a decrease of 78.2%[20] - The company’s total comprehensive income for Q1 2023 was CNY 458,324,740.05, down from CNY 2,138,021,268.64 in Q1 2022, a decrease of 78.6%[21] Cash Flow - The net cash flow from operating activities was -¥496,495,375.75, a decline of 136.87% compared to ¥1,346,690,853.53 in the same period last year[5] - In Q1 2023, the company's cash inflow from operating activities was CNY 4,693,507,419.08, a decrease of 28.7% compared to CNY 6,582,042,128.78 in Q1 2022[22] - The net cash flow from operating activities was negative at CNY -496,495,375.75, contrasting with a positive CNY 1,346,690,853.53 in the same period last year[23] - Total cash outflow from operating activities was CNY 5,190,002,794.83, slightly down from CNY 5,235,351,275.25 in Q1 2022[23] - The company reported a cash inflow from investment activities of CNY 23,454,980.42, up from CNY 12,348,101.40 in Q1 2022[23] - Cash outflow from investment activities increased to CNY 727,650,883.25 from CNY 443,417,574.92 year-over-year[23] - The net cash flow from financing activities was CNY 272,691,873.62, a significant improvement from CNY -934,234,801.01 in Q1 2022[23] - The ending balance of cash and cash equivalents was CNY 3,709,176,328.10, compared to CNY 2,926,729,388.89 at the end of Q1 2022[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥42,541,860,176.42, an increase of 2.19% from ¥41,630,002,403.69 at the end of the previous year[5] - The company reported a total liability of CNY 20,519,686,496.19 as of Q1 2023, an increase from CNY 20,286,529,548.24 in the previous year[17] - The total equity attributable to shareholders of the parent company was CNY 20,967,426,865.46, up from CNY 20,307,801,046.01 in Q1 2022, indicating an increase of 3.2%[18] - The company’s total non-current liabilities increased to CNY 10,312,785,657.56 from CNY 9,632,292,076.15, marking an increase of 7.0%[17] Inventory and Investments - Current assets totaled approximately CNY 9.63 billion, up from CNY 9.27 billion at the end of 2022, indicating an increase of about 3.9%[15] - The company's inventory decreased to approximately CNY 2.32 billion from CNY 2.52 billion, representing a decline of about 7.8% year-over-year[15] - The long-term equity investments rose to approximately CNY 2.04 billion, compared to CNY 1.94 billion at the end of 2022, marking an increase of about 5.5%[15] - The company’s accounts receivable increased to approximately CNY 1.49 billion from CNY 928 million, showing a significant rise of about 60.3%[15] Research and Development - Research and development expenses for Q1 2023 were CNY 250,307,637.77, a decrease of 10.3% compared to CNY 279,109,094.59 in Q1 2022[19] - The company did not report any new product or technology developments during this quarter[24] Market and Product Performance - The net profit attributable to shareholders significantly decreased compared to the same period last year, primarily due to a substantial decline in market prices for glyphosate and organic silicon DMC, with glyphosate prices nearing the industry cost line by the end of Q1 2023[13] - The company experienced a significant decline in the production and sales volume of glyphosate and organic silicon products, which negatively impacted overall profitability[13] - The company reported stable demand and profitability for growth products such as wet electronic chemicals, specialty chemicals, and food additives, which have become the main contributors to performance[13] - The company plans to focus on expanding its market presence and developing new products to enhance profitability in the upcoming quarters[13]

Financial Performance - The company's operating revenue for 2022 was CNY 30.31 billion, representing a 26.81% increase compared to CNY 23.90 billion in 2021[20]. - The net profit attributable to shareholders for 2022 was CNY 5.85 billion, a 36.67% increase from CNY 4.28 billion in 2021[20]. - The net cash flow from operating activities for 2022 was CNY 6.88 billion, up 28.52% from CNY 5.36 billion in 2021[20]. - The total assets at the end of 2022 were CNY 41.61 billion, reflecting a 12.85% increase from CNY 36.74 billion at the end of 2021[20]. - The basic earnings per share for 2022 was CNY 5.31, a 36.86% increase from CNY 3.88 in 2021[21]. - The diluted earnings per share for 2022 was CNY 5.21, up 35.32% from CNY 3.85 in 2021[21]. - The company reported a weighted average return on equity of 34.76% for 2022, a decrease of 1.79 percentage points from 36.55% in 2021[21]. - The company achieved a sales revenue of 30.31 billion RMB, representing a year-on-year growth of 26.81%[47]. - The net profit attributable to shareholders reached 5.85 billion RMB, with a year-on-year increase of 36.67%[47]. Dividend Policy - The company plans to distribute a cash dividend of 10 CNY per 10 shares, totaling approximately 1,111,670,663 CNY, which represents a 100% increase in cash dividends per share compared to 2021[5]. - The cash dividend payout ratio is 19.00% of the net profit attributable to shareholders, which is below the 30% threshold due to significant performance growth in 2022[5]. - The board of directors has considered balancing current funding needs with future development investments when proposing the profit distribution plan[5]. - The company has a cash dividend policy that emphasizes shareholder returns, with a clear standard and proportion for dividends, ensuring the protection of minority shareholders' rights[134]. Research and Development - Research and development investment totaled 1.24 billion CNY, with a focus on innovative projects and technology advancements[28]. - The company has a total of 864 authorized patents, including 277 invention patents, reflecting its commitment to innovation[28]. - The company’s R&D team consists of 252 personnel, with 75% holding master's degrees or higher, emphasizing its focus on high-level talent[28]. - The company has developed over 40 key technology projects and holds 864 patents, including 277 invention patents, showcasing its innovation capabilities[39]. - The company is committed to enhancing its R&D capabilities by attracting high-end talent and establishing a flexible talent exchange mechanism[82]. Strategic Transformation - The company is undergoing a transformation from a traditional chemical enterprise to a modern technology-driven and green chemical new materials enterprise, indicating a focus on R&D and project construction[5]. - The company’s strategic shift towards becoming a technology-driven green chemical materials enterprise is ongoing, with a focus on enhancing its competitive edge in the market[27]. - The company plans to continue expanding its market presence and investing in new product development to drive future growth[20]. - The company is focusing on high-end new materials and renewable energy industries, enhancing its strategic layout and R&D investment[41]. Environmental and Social Responsibility - The company reported a 30% reduction in overall emissions and a 50% decrease in annual water consumption at the Yichang New Materials Industrial Park[46]. - The company is actively pursuing ecological protection initiatives, completing five major projects related to environmental management[46]. - The company has invested approximately 43.58 million yuan in environmental protection during the reporting period[144]. - The company has established environmental protection mechanisms and is classified as a key pollutant discharge unit by environmental authorities[144]. - Total investment in social responsibility projects amounted to 156.3 million yuan, with 149.3 million yuan in cash donations[169]. Market Expansion and Competitiveness - The company is actively developing new technologies and products to enhance its market competitiveness and expand its influence in the industry[32][33][34][35][36]. - The company is focusing on the development of new technologies and products in the fields of microelectronics and new energy[104]. - The company aims to expand its formulation business and optimize silicone production processes to control costs while increasing market share in specialty products[106]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million yuan for potential deals[116]. Financial Management and Governance - The company has a structured remuneration system that includes basic salary, performance pay, reward pay, and outstanding contribution bonuses for senior management[122]. - The company has established a remuneration committee to oversee the assessment and distribution of senior management pay[122]. - The company has a clear plan for future governance, with all board members' terms set to end in 2024, allowing for potential strategic changes[114]. - The company has maintained independence in operations, with no interference from controlling shareholders in major decisions during the reporting period[111]. Risks and Compliance - The company acknowledges potential risks that may adversely affect its future development strategies and operational goals[8]. - The company is facing risks from price fluctuations in chemical products due to market dynamics, and it plans to adjust product structures and enhance cost control measures[108]. - The company has committed to ensuring that it does not engage in similar violations in the future by reinforcing compliance among its executives[183]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[163].

Financial Performance - The company's operating revenue for Q3 2022 was RMB 7,557,100,484.46, representing a 10.34% increase compared to RMB 6,848,900,000 in the same period last year[4]. - Net profit attributable to shareholders for Q3 2022 was RMB 1,261,106,154.03, a decrease of 7.73% from RMB 1,366,788,742.05 in the previous year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 1,290,613,981.10, down 16.33% from RMB 1,542,472,748.58 year-on-year[5]. - Total profit increased by 121.38%, attributed to improved profitability during the period[11]. - The net profit for Q3 2022 was CNY 5,822,758,950.01, a significant increase from CNY 2,770,901,568.38 in Q3 2021, representing an increase of approximately 109.5%[20]. - The operating profit for Q3 2022 was CNY 7,306,637,021.22, up from CNY 3,543,169,504.74 in Q3 2021, reflecting an increase of approximately 106.5%[20]. - The basic earnings per share for Q3 2022 was CNY 4.4610, compared to CNY 2.3054 in Q3 2021, marking an increase of about 93.6%[21]. - The total comprehensive income for Q3 2022 was CNY 5,878,859,506.60, compared to CNY 2,768,452,918.83 in Q3 2021, indicating an increase of about 112.5%[21]. Assets and Liabilities - The company's total assets at the end of the reporting period were RMB 41,161,489,860.25, an increase of 12.05% compared to RMB 36,735,153,693.65 at the end of the previous year[5]. - The company's total assets as of the third quarter of 2022 were ¥41,161,489,860.25, compared to ¥36,735,153,693.65 at the end of the previous year, marking an increase of about 12.4%[18]. - Non-current assets totaled ¥30,706,784,449.05, up from ¥27,665,971,490.42, representing a growth of approximately 11.0%[17]. - The total liabilities as of the third quarter of 2022 were ¥20,928,094,671.38, slightly up from ¥20,904,723,624.22 in the previous year, indicating a marginal increase of about 0.1%[18]. - The company's equity attributable to shareholders reached ¥19,250,898,183.36, compared to ¥14,280,303,032.51 in the same period of 2021, reflecting a growth of approximately 35.0%[18]. Cash Flow - Cash flow from operating activities for the year-to-date was RMB 6,130,576,342.96, representing a 130.71% increase compared to RMB 2,657,225,161.99 in the previous year[5]. - The company reported a net cash inflow from operating activities of 130.71 million, driven by increased revenue and improved collection of sales[11]. - The net cash flow from operating activities for Q3 2022 was CNY 6,130,576,342.96, compared to CNY 2,657,225,161.99 in Q3 2021, representing an increase of approximately 130.5%[23]. - The cash and cash equivalents at the end of Q3 2022 amounted to CNY 5,470,451,026.12, a significant increase from CNY 1,599,810,959.39 at the end of Q3 2021[24]. - The company reported a net cash outflow from investing activities of CNY 1,382,118,772.91 for Q3 2022, compared to a net outflow of CNY 1,457,844,501.21 in Q3 2021[23]. - The company’s total liabilities increased, with cash inflow from financing activities totaling CNY 8,457,148,909.73 in Q3 2022, compared to CNY 7,460,708,296.19 in Q3 2021, reflecting an increase of approximately 13.4%[23]. Research and Development - Research and development expenses rose by 88.92%, reflecting a significant increase in investment in R&D[11]. - Research and development expenses for the first three quarters of 2022 amounted to ¥947,481,310.72, up from ¥501,517,163.95 in the same period of 2021, reflecting an increase of approximately 88.9%[19]. Acquisitions and Investments - The company plans to acquire 100% equity of Ningtong Logistics for RMB 239,173,100 and 51% equity of Xingxing Lantian for RMB 259,140,600, indicating a strategy for market expansion through acquisitions[6][7]. - The company completed a convertible bond issuance of RMB 2.8 billion, significantly increasing its cash reserves by 71.05%[9]. - The company issued convertible bonds, resulting in an increase in cash and cash equivalents by 241.94 million[11]. - The company reported a loss of RMB 64,027,643.21 from the disposal of non-current assets in the current period[7]. Accounts Receivable and Inventory - The company experienced a 48.92% increase in accounts receivable due to higher revenue, reflecting improved sales performance[9]. - Accounts receivable rose to ¥1,390,407,985.85, compared to ¥933,685,383.72 in the previous year, indicating an increase of approximately 49.0%[16]. - Inventory decreased to ¥1,874,039,157.88 from ¥2,446,669,295.46, reflecting a decline of about 23.4%[16]. Taxation - The company recorded a 196.29% increase in income tax expenses, corresponding to the rise in profits[11]. - The company’s income tax expense for Q3 2022 was CNY 1,232,007,998.83, compared to CNY 415,808,488.34 in Q3 2021, indicating an increase of about 196.5%[20].

Financial Performance - The company reported a total revenue of 1.5 billion CNY for the first half of 2022, representing a year-on-year increase of 10%[10]. - The net profit attributable to shareholders was 300 million CNY, up 15% compared to the same period last year[10]. - The company's operating revenue for the first half of the year reached ¥17.30 billion, a 74.45% increase compared to ¥9.92 billion in the same period last year[17]. - Net profit attributable to shareholders was ¥3.65 billion, reflecting a significant increase of 211.62% from ¥1.17 billion year-on-year[17]. - The net profit after deducting non-recurring gains and losses was ¥3.70 billion, up 232.57% from ¥1.11 billion in the previous year[17]. - Basic earnings per share increased to ¥3.28, a rise of 213.76% from ¥1.05 in the same period last year[19]. - The total profit amounted to ¥5,255,813,132.28, reflecting a 260.18% increase from the previous year[40]. - The company achieved a net cash inflow from operating activities of approximately CNY 6.95 billion for the first half of 2022, down from CNY 7.63 billion in the same period of 2021, showing a decline of 9%[149]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 25% growth in that region by the end of 2023[10]. - The management has set a performance guidance of 10-15% revenue growth for the second half of 2022[10]. - The company has no plans for major acquisitions in the near term, focusing instead on organic growth strategies[10]. - The company is focused on expanding its integrated industrial chain, enhancing its capabilities in fine phosphorus chemicals, and exploring synergies with other sectors such as silicon and lithium[22]. - The company plans to continue optimizing its supply chain management and procurement processes to ensure cost efficiency and product quality[22]. Research and Development - The company has allocated 100 million CNY for research and development in new technologies for the upcoming fiscal year[10]. - The company has accumulated strong R&D capabilities in fine phosphate salts, with several technologies awarded top honors in provincial competitions[25]. - Research and development expenses for the reporting period amounted to 656 million RMB, with 83 new patents granted, bringing the total to 733 patents[38]. - The company is actively involved in the development of high-performance silicone materials and has established a research center in collaboration with the Shenzhen Institute of Advanced Technology[30]. Environmental Compliance and Sustainability - The company has implemented various environmental protection measures, significantly improving resource utilization and promoting green development[36]. - The company’s phosphate mining operations are recognized as national-level green mines, reflecting its commitment to sustainable practices[24]. - The company has established a comprehensive environmental monitoring system to ensure compliance with pollution discharge standards, with real-time monitoring of emissions[86]. - The company has reported no instances of exceeding emission limits across all monitored pollutants[75]. Financial Stability and Liabilities - The asset-liability ratio decreased to 50.09% by the end of the reporting period, indicating improved financial stability[38]. - The company has maintained a loan repayment rate of 100% and an interest payment rate of 100%, ensuring timely debt servicing[135]. - Total liabilities amounted to ¥19,296,159,469.49, down from ¥20,904,723,624.22, showing a decline of about 7.7% year-over-year[139]. - The company's cash and cash equivalents decreased to ¥418,071,757.19 from ¥917,986,271.34, a decline of about 54.5%[140]. Shareholder and Corporate Governance - The company appointed two independent directors, Xue Dongfeng and Hu Guorong, during the board meetings held on March 19 and April 25, 2022[61]. - The company has committed to maintaining control over the listed company and will not relinquish its rights to nominate board members or vote at shareholder meetings[102]. - The company has established a market-based pricing principle for its related party transactions[109]. - The company confirmed no major litigation or arbitration matters during the reporting period[106]. Product Development and Market Demand - New product development includes the launch of a high-performance silicone material, expected to contribute an additional 200 million CNY in revenue[10]. - The company reported strong demand for its products, including phosphate rock and glyphosate, driven by a booming agricultural market and rapid development in food processing and other industries[20]. - The global demand for glyphosate is expected to remain stable due to the increasing planting area of genetically modified crops[26]. Employment and Community Engagement - Approximately 20 employment policy promotion events were held, resulting in the recruitment of about 90 local workers[96]. - The company provided over 200 job positions for local villagers and invested 15,900 yuan in social security insurance for poverty alleviation households[96]. - The company has actively engaged in rural revitalization efforts, developing 1,000 acres of vegetable planting and raising over 300 pigs in targeted poverty alleviation areas[95].

Financial Performance - The company's operating revenue for Q1 2022 was RMB 8,574,950,101.46, representing a 90.65% increase compared to RMB 4,497,802,347.86 in the same period last year[4] - Net profit attributable to shareholders was RMB 1,719,767,113.29, a significant increase of 384.64% from RMB 354,851,877.78 in the previous year[4] - Basic and diluted earnings per share were both RMB 1.55, reflecting a 387.99% increase compared to RMB 0.32 in the same period last year[5] - The weighted average return on equity increased by 7.98 percentage points to 11.61% from 3.63% in the previous year[5] - The increase in revenue and profit was primarily driven by rising sales volumes and prices of the company's main products[9] - Total operating revenue for Q1 2022 reached ¥8,574,950,101.46, a significant increase of 90.5% compared to ¥4,497,802,347.86 in Q1 2021[19] - Net profit for Q1 2022 was ¥2,116,336,693.48, up 453.5% from ¥382,541,175.77 in Q1 2021[20] - Earnings per share for Q1 2022 was ¥1.55, compared to ¥0.32 in Q1 2021, reflecting a substantial growth[21] - Total comprehensive income for Q1 2022 was ¥2,115,367,118.62, compared to ¥383,132,739.75 in Q1 2021, showing a growth of 451.5%[21] Cash Flow - The net cash flow from operating activities reached RMB 1,290,517,160.34, up 190.31% from RMB 444,527,011.80 year-on-year[5] - Cash flow from operating activities was ¥6,574,326,074.60 in Q1 2022, significantly higher than ¥3,704,187,824.20 in Q1 2021, marking an increase of 77.5%[22] - The net cash flow from operating activities was $1,290,517,160.34, an increase from $444,527,011.80 in the previous period[23] - The total cash outflow from investing activities amounted to $415,547,037.01, compared to $257,029,965.78 previously[23] - The net cash flow from financing activities was -$889,298,682.96, worsening from -$500,116,264.94 in the prior period[23] - The cash and cash equivalents at the end of the period reached $2,900,289,745.95, up from $1,334,721,315.56 at the beginning[23] - Cash inflow from financing activities totaled $2,252,273,117.44, compared to $3,103,939,992.52 in the previous period[23] - The cash outflow for debt repayment was $2,764,536,332.07, a decrease from $3,300,455,188.03[23] - The cash flow from investing activities resulted in a net outflow of -$403,198,935.61, compared to -$181,736,722.67 previously[23] Assets and Liabilities - The total assets at the end of the reporting period were RMB 35,919,105,097.84, marking a 4.17% increase from RMB 34,480,684,634.50 at the end of the previous year[5] - Current assets totaled RMB 9,129,545,293.86, up from RMB 8,697,358,769.34, indicating an increase of about 5.0% year-over-year[16] - The company's accounts receivable rose significantly to RMB 1,831,269,610.94 from RMB 930,299,867.71, representing an increase of approximately 96.7%[16] - Inventory decreased to RMB 1,866,297,846.61 from RMB 2,393,520,187.01, showing a decline of about 22.0%[16] - Total liabilities decreased to RMB 18,364,372,647.53 from RMB 18,889,603,666.69, a reduction of approximately 2.8%[17] - The company's short-term borrowings were reported at RMB 3,246,574,630.92, down from RMB 4,052,498,666.98, indicating a decrease of about 19.9%[17] - The company's total assets as of March 31, 2022, amounted to RMB 35,919,105,097.84, an increase from RMB 34,480,684,634.50 at the end of 2021, reflecting a growth of approximately 4.2%[15] - The company's total liabilities and equity reached ¥17,554,732,450.31 in Q1 2022, up from ¥15,591,080,967.81 in Q1 2021, reflecting an increase of 12.6%[18] Investments and Acquisitions - The company plans to expand its market presence through the acquisition of 100% equity in Ningtong Logistics for RMB 239.1731 million, which is expected to enhance operational capabilities[6] - Research and development expenses increased to ¥279,109,094.59 in Q1 2022, up 135.5% from ¥118,618,772.36 in Q1 2021[19] - Investment income for Q1 2022 was ¥113,316,638.03, compared to ¥30,177,514.57 in Q1 2021, indicating a growth of 274.5%[20] Operational Strategy - The company maintained a strong focus on its core products, with high sales prices for glyphosate, yellow phosphorus, and phosphate fertilizers continuing to support revenue growth[14] - The company is leveraging its integrated industrial chain advantages to optimize production and operations, contributing to improved financial performance[14] - The company is actively pursuing market opportunities while adhering to safety and environmental standards, which is expected to enhance future growth prospects[14] Non-Recurring Items - Non-recurring gains and losses included government subsidies amounting to RMB 15,057,514.17, while losses from the disposal of non-current assets were RMB 9,241,218.52[7] - The company reported a decrease in other comprehensive income, with a net amount of -¥969,574.86 in Q1 2022 compared to ¥591,563.98 in Q1 2021[21] Exchange Rate Impact - The impact of exchange rate changes on cash and cash equivalents was $2,582,609.13, up from $1,516,721.08[23]